Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Tamoxifen: Teaching an old drug new tricks?

Nature Medicine volume 2, pages 381–385 (1996)Cite this article

Tamoxifen and its analogues are powerful tools in the fight against breast cancer and may soon find applications fighting other diseases such as atherosclerosis and osteoporosis.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Santambrogio, L. et al. Studies on the mechanisms by which transforming growth factor-β protects against allergic encephalomyelitis — antagonism between TGF-β and tumour necrosis factor. J. Immunol. 151, 116–1127 (1993).

    Google Scholar 

  2. Ward, R.L., Morgan, G.;., Dalley, D. & Kelly, P.J. Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal women. Bone Miner. 22, 87–94 (1993).

    Article  CAS  Google Scholar 

  3. Grainger, D.J., Witchell, C.M. & Metcalfe, J.C. Tamoxifen elevates transforming growth factor-β and suppresses diet-induced formation of lipid lesions in mouse aorta. Nature Med. 1, 1067–1072 (1995).

    Article  CAS  Google Scholar 

  4. van Leeuwen, F.E. et al. Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 343, 448–452 (1994).

    Article  CAS  Google Scholar 

  5. Rutquist, L.E. et al. Adjuvant tamoxifen therapy for early-stage breast cancer and second primary malignancies. J. Natl Cancer Inst. 87, 645–651 (1995).

    Article  Google Scholar 

  6. Potter, G.A., McCague, R. & Jarman, M. A mechanistic hypothesis for DNA adduct formation by tamoxifen following hepatic oxidative metabolism. Carcinogenesis 15, 439–442 (1994).

    Article  CAS  Google Scholar 

  7. Karnik, P.S., Kulkarni, S., Liu, X.P., Budd, G.T. & Bukowski, R.M. Estrogen-receptor mutations in tamoxifen resistant breast cancer. Cancer Res. 54, 349–353 (1994).

    CAS  PubMed  Google Scholar 

  8. Colletta, A.A. et al. Anti-oestrogens induce the secretion of active transforming growth factor β from human fetal fibroblasts. Br. J. Cancer 62, 405–409 (1990).

    Article  CAS  Google Scholar 

  9. Jeng, M.H., Tendijke, P., Iwata, K.K. & Jordan, V.C. Regulation of the levels of three transforming growth factor-β mRNAs by estrogen and their effects on the proliferation of human breast cancer cells. Mol Cell. Endocrinol. 92, 115–123 (1993).

    Article  Google Scholar 

  10. Butta, A. et al. Induction of transforming growth factor β1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res. 52, 4261–4264 (1992).

    CAS  Google Scholar 

  11. Markowitz, S. et al. Inactivation of the type II TGF-β receptor in colon cancer cells with micro-satellite instability. Science 268, 1336–1338 (1995).

    Article  CAS  Google Scholar 

  12. Pierce, D.F. et al. Mammary tumour suppression by transforming growth factor β1 transgene expression. Proc. Natl. Acad. Sci. USA 92, 4254–4258 (1995).

    Article  CAS  Google Scholar 

  13. Torre-Amione, G. et al. A highly immunogenic tumour transfected with a murine transforming growth factor type β1 cDNA escapes immune surveillance. Proc. Natl. Acad. Sci. USA 87, 1486–1490 (1990).

    Article  CAS  Google Scholar 

  14. Langdahl, B.L., Brixen, K., Jensen, H.K., Gregersen, N. & Eriksen, E.F. Mutations in the TGF-beta-1 gene are correlated to low bone mass and increased bone turnover. J. Bone Mineral Res. 10, abstract 185 (1995).

    Google Scholar 

  15. MacDonald, C.C. & Stewart, H.J. Fatal myocar-dial infarction in the Scottish adjuvant tamoxifen trial. Br. Med. J. 303, 435–437 (1991).

    Article  Google Scholar 

  16. MacDonald, C.C., Alexander, F.E., Whyte, B.W., Forrest, A.P. & Stewart, H.J. Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. Brit. Med.J. 311, 977–980 (1995).

    Article  Google Scholar 

  17. Grainger, D.J. Metcalfe, J.C. DJ Metcalfe, J.C. A pivotal role for TGF-β in atherogenesis? Biol. Rev. Camb. Philos. Soc. 70, 571–596 (1995).

    Article  CAS  Google Scholar 

  18. Grainger, D.J., Kemp, P.R., Liu, A.C., Lawn, R.M. & Metcalfe, J.C. Activation of transforming growth factor β is inhibited in transgenic apolipopro-tein(a) mice. Nature 370, 460–462 (1994).

    Article  CAS  Google Scholar 

  19. Stein, B. & Yang, M.X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NFKB and C/EBPβ. Mol. Cell. Biol. 15, 4971–4979 (1995).

    Article  CAS  Google Scholar 

  20. Caldenhoven, E. et al. Negative cross-talk between RelA and the glucocorticoid receptor: A possible mechanism for the anti-inflammatory action of glucocorticoids. Mol. Endocrinol. 9, 401–412 (1995).

    CAS  PubMed  Google Scholar 

  21. Mauviel, A., Chen, Y.Q., Dong, W., Evans, C.H. & Ditto, J. Transcriptional interactions of TGF-p with pro-inflammatory cytokines. Curr. Biol. 3, 822–831 (1993).

    Article  CAS  Google Scholar 

  22. Border, W.A. & Noble, N.A., TGF-β for treatment of disease. Nature Med. 1, 1000–1001 (1995).

    Article  CAS  Google Scholar 

  23. Magarian, R.A., Overacre, L.B., Singh, S. & Meyer, K.L. The medicinal chemistry of non-steroidal antiestrogens: A review. Curr. Med. Chem. 1, 61–104 (1994).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QW, UK

    David J. Grainger & James C. Metcalfe

Authors
  1. David J. Grainger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James C. Metcalfe
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grainger, D., Metcalfe, J. Tamoxifen: Teaching an old drug new tricks?. Nat Med 2, 381–385 (1996). https://doi.org/10.1038/nm0496-381

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0496-381

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing